PDE11A anticorps
-
- Antigène Voir toutes PDE11A Anticorps
- PDE11A (phosphodiesterase 11A (PDE11A))
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp PDE11A est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Réactivité croisée
- Humain
- Purification
- Purified by antigen-affinity chromatography.
- Immunogène
- Recombinant protein encompassing a sequence within the center region of human PDE11A. The exact sequence is proprietary.
- Isotype
- IgG
- Top Product
- Discover our top product PDE11A Anticorps primaire
-
-
- Indications d'application
- WB: 1:1000-1:10000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
- Commentaires
-
Positive Control: HepG2
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- 0.1M Tris-Glycine ( pH 7), 10 % Glycerol, 0.01 % Thimerosal
- Agent conservateur
- Thimerosal (Merthiolate)
- Précaution d'utilisation
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
- Antigène
- PDE11A (phosphodiesterase 11A (PDE11A))
- Autre désignation
- phosphodiesterase 11A (PDE11A Produits)
- Synonymes
- anticorps PPNAD2, anticorps 6330414F14Rik, anticorps A630086N24Rik, anticorps Gm350, anticorps PDE11A1, anticorps si:ch211-222f23.5, anticorps PDE11A, anticorps ppnad2, anticorps Pde11a, anticorps phosphodiesterase 11A, anticorps phosphodiesterase 11a, anticorps dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, anticorps PDE11A, anticorps Pde11a, anticorps pde11a, anticorps LOC100470038
- Sujet
- Phosphodiesterase 11A , PPNAD2,The 3',5'-cyclic nucleotides cAMP and cGMP function as second messengers in a wide variety of signal transduction pathways. 3',5'-cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cGMP to the corresponding 5'-monophosphates and provide a mechanism to downregulate cAMP and cGMP signaling. This gene encodes a member of the PDE protein superfamily. Mutations in this gene are a cause of Cushing disease and adrenocortical hyperplasia. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq]
- Poids moléculaire
- 105 kDa
- ID gène
- 50940
- UniProt
- Q9HCR9
- Pathways
- cAMP Metabolic Process
-